Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of Mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in The Gambia
Journal of Clinical Microbiology, Volume 43, No. 5, Year 2005
Notification
URL copied to clipboard!
Description
Overlapping peptides of Mycobacterium tuberculosis antigens ESAT-6 and CFP-10 offer increased specificity over the purified protein derivative skin test when they were used in an ex vivo enzyme-linked immunospot (ELISPOT) assay for gamma interferon detection for the diagnosis of M. tuberculosis infection from recent exposure. We assessed whether equivalent results could be obtained for a fusion protein of the two antigens and whether a combined readout would offer increased sensitivity in The Gambia. We studied the ELISPOT assay results for 488 household contacts of 88 sputum smear-positive tuberculosis (TB) cases. The proportions of subjects positive by each test and by the tests combined were assessed across an exposure gradient, defined according to sleeping proximity to a TB case. Eighty-eight (18%) subjects were positive for CFP-10 peptides, 148 (30%) were positive for ESAT-6 peptides, 161 (33%) were positive for both peptides, and 168 (34%) were positive for the fusion protein; 188 (39%) subjects had either a positive result for a peptide or a positive result for the fusion protein. There was reasonable agreement between the peptide and the protein results (kappa statistic = 0.78) and no significant discordance (P = 0.38). There was a strong correlation between the fusion protein and combined peptide spot counts (r = 0.9), and responses to the peptide and the proteins all increased significantly according to M. tuberculosis exposure. The proportion of subjects positive for either the pool of peptides or the fusion protein offered maximum sensitivity, being significantly higher than the proportion of subjects positive for ESAT-6 peptides alone (P = 0.007). A fusion protein of ESAT-6 and CFP-10 is equivalent to overlapping peptides for the diagnosis of latent M. tuberculosis infection. Use of a combination of peptides and fusion protein offers improved sensitivity. Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Authors & Co-Authors
Hill, Philip C.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Jackson-Sillah, Dolly J.
Gambia, Banjul
Medical Research Council Laboratories Gambia
FOX, A.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Franken, Kees L.M.C.
Netherlands, Leiden
Leids Universitair Medisch Centrum
Lugos, M. D.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Jeffries, David J.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Donkor, Simon A.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Hammond, Abdulrahman S.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Adegbola, Richard A.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Ottenhoff, Tom H.M.
Netherlands, Leiden
Leids Universitair Medisch Centrum
Klein, Michél R.
Netherlands, Leiden
Leids Universitair Medisch Centrum
Brookes, Roger H.
Gambia, Banjul
Medical Research Council Laboratories Gambia
Statistics
Citations: 59
Authors: 12
Affiliations: 2
Identifiers
Doi:
10.1128/JCM.43.5.2070-2074.2005
ISSN:
00951137
Research Areas
Infectious Diseases
Study Locations
Gambia